Skip to content
Trial Eligibility
Menu

Crohn's Disease Clinical Trials near Chicago, IL

16 studies for Crohn's Disease are recruiting at 31 sites within 50 miles of Chicago, Illinois, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Crohn's Disease trials in the US or all trials near Chicago.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Crohn's Disease studies enrolling near Chicago

Showing 16 studies, nearest first.
  1. An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

    NCT07184931

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: Rush University Medical Center-Site Number: 8400015 (Chicago, IL); GI Alliance - Glenview-Site Number: 8400068 (Glenview, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  2. A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

    NCT06430801

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: University of Chicago Medical Center ( Site 5066) (Chicago, IL); Endeavor Health ( Site 5018) (Evanston, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  3. A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

    NCT06819878

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: Northwestern Memorial Hospital (Chicago, IL); Illinois Gastroenterology Group-Glenview powered by GI Alliance (Glenview, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  4. Treatment of Moderate to Severe Refractory Crohn's Disease

    NCT06721962

    • Phase 1/2
    • Ages 18 to 65 years
    • Sex: All

    Nearest sites: Northwestern (Chicago, IL); University of Chicago (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  5. Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

    NCT05230173

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Chicago Medicine (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  6. A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

    NCT06045754

    • Phase 4
    • Ages 18 to 70 years
    • Sex: All

    Nearest site: University of Chicago Medicine (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  7. Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

    NCT06548542

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: University of Chicago Medical Center /ID# 267400 (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  8. A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

    NCT06819891

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest site: The University of Chicago (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

    NCT06937099

    • Phase 3
    • Ages 18 to 70 years
    • Sex: All

    Nearest site: Rush University Medical Center (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

    NCT06581328

    • Phase 4
    • Ages 18 to 80 years
    • Sex: All

    Nearest sites: GI Partners of Illinois - Southwest Gastroenterology (Oak Lawn, IL); GI Alliance - Glenview (Glenview, IL)

    Distance to nearest recruiting site
    ~11 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  11. Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

    NCT07697456

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Southwest Gastroenterology - Oak Lawn /ID# 280841 (Oak Lawn, IL); Gi Alliance - Glenview /ID# 283932 (Glenview, IL)

    Distance to nearest recruiting site
    ~11 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  12. Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

    NCT06456593

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Northwestern University (Evanston, IL)

    Distance to nearest recruiting site
    ~13 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

    NCT04779320

    • Phase 3
    • Ages 2 to 17 years
    • Sex: All

    Nearest site: Advocate Children's Hospital Park Ridge (Park Ridge, IL)

    Distance to nearest recruiting site
    ~15 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

    NCT05442567

    • Phase 3
    • Ages 2 years and older
    • Sex: All

    Nearest site: Advocate Children's Hospital - Park Ridge - PIN (Park Ridge, IL)

    Distance to nearest recruiting site
    ~15 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

    NCT07113522

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest sites: Mirador Therapeutics Selected Site (Glenview, IL); Mirador Therapeutics Selected Site (Gurnee, IL)

    Distance to nearest recruiting site
    ~17 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  16. A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

    NCT07184944

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest site: Illinois Gastroenterology Group d/b/a GI Alliance - Gurnee-Site Number: 8400049 (Gurnee, IL)

    Distance to nearest recruiting site
    ~38 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Crohn's Disease clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.